WCLC 2025 - Posters & ePosters-P3.18.57 Phase 1/2 Clinical Trial of JIN-A02, a 4th Generation EGFR-TKI in EGFR Mutant Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

P3.18.57 Phase 1/2 Clinical Trial of JIN-A02, a 4th Generation EGFR-TKI in EGFR Mutant Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Asset Subtitle

Sun-Min Lim

Meta Tag

Speaker Sun-Min Lim

Topic Clinical Trials in Progress